HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Does FDA Deem A "Serious Adverse Event"? Matrixx Learns The Hard Way

This article was originally published in The Rose Sheet

Executive Summary

A narrower interpretation of "serious adverse event" - compared with FDA's definition - is costing Matrixx Initiatives at least $10 million dollars with the recall of its intranasal Zicam products - assuming FDA cannot be convinced to reverse its position

You may also be interested in...



Warnings In 2019, AERs In 2009: Touchstones Toward Homeopathic Guidance

Priority enforcement areas listed in draft guidance note delivery formats other than oral and topical, such as nasal gel product that was early alarm in FDA's evaluation of safety and efficacy across homeopathic market. Recent warnings also noted in revised draft.

Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers

Putting FDA's aggressive enforcement plan into action will require more creativity on the part of agency lawyers, according to FDA's commissioner and chief counsel

Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers

Putting FDA's aggressive enforcement plan into action will require more creativity on the part of agency lawyers, according to FDA's commissioner and chief counsel

Related Content

UsernamePublicRestriction

Register

RS016253

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel